Actions for Glaucoma : an open window to neurodegeneration and neuroprotection

Email RIS file
Bookmark
Report an Issue

Glaucoma : an open window to neurodegeneration and neuroprotection / edited by Carlo Nucci [and others].

Published
Amsterdam ; Boston : Elsevier, 2008.
Physical Description
xvi, 622 pages, 16 unnumbered pages of plates : illustrations (some color) ; 26 cm.
Additional Creators
Nucci, Carlo

Availability

Browse Nearby on Shelf
I Want It
I Want It

Finding items...

Series
Contents
1. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects -- 2. Predictive models to estimate the risk of glaucoma development and progression -- 3. Intraocular pressure and central corneal thickness -- 4. Angle-closure: risk factors, diagnosis and treatment -- 5. Early diagnosis of glaucoma -- 6. Monitoring glaucoma progression -- 7. Standard automated perimetry and algorithms for monitoring glaucoma progression -- 8. Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma -- 9. Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma -- 10. The role of OCT in glaucoma management -- 11. Functional laser Doppler flowmetry of the optic nerve: physiological aspects and clinical applications -- 12. Advances in neuroimaging of the visual pathways and their use in glaucoma -- 13. Primary open angle glaucoma: an overview of medical therapy -- 14. The treatment of normal-tension glaucoma -- 15. The management of exfoliative glaucoma -- 16. Laser therapies for glaucoma: new frontiers -- 17. Modulation of wound healing during and after glaucoma surgery -- 18. Surgical alternative to trabeculectomy -- 19 Modern aqueous shunt implantation: future challenges -- 20. Model systems for experimental studies: retinal ganglion cells in culture -- 21. Rat models for glaucoma research -- 22. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection -- 23. Clinical trials in neuroprotection. and 24. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria -- 25. Astrocytes in glaucomatous optic neuropathy -- 26. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation -- 27. Oxidative stress and glaucoma: injury in the anterior segment of the eye -- 28 TNF-alpha signaling in glaucomatous neurodegeneration -- 29. Involvement of the Bc12 gene family in the signaling and control of retinal ganglion cell death -- 30. Assessment of neuroprotection in the retina with DARC -- 31. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection -- 32. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration -- 33. Changes of central visual receptive fields on experimental glaucoma -- 34. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma -- Stem cells for neuroprotection in glaucoma -- 36. The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells -- 37. Evidence of the neuroprotective role of citicoline in glaucoma patients -- 38. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon -- 39. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection -- 40. 17Beta-estradiol prevents retinal ganglion cell loss induced by the acute rise of intraocular pressure in rat.
Subject(s)
ISBN
9780444532565 (cased)
0444532560 (cased)
Bibliography Note
Includes bibliographical references and index.
View MARC record | catkey: 5199798